ZA939804B - Immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen - Google Patents
Immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigenInfo
- Publication number
- ZA939804B ZA939804B ZA939804A ZA939804A ZA939804B ZA 939804 B ZA939804 B ZA 939804B ZA 939804 A ZA939804 A ZA 939804A ZA 939804 A ZA939804 A ZA 939804A ZA 939804 B ZA939804 B ZA 939804B
- Authority
- ZA
- South Africa
- Prior art keywords
- immunogenicity
- cytokine
- vaccine
- antigen
- immune
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99906692A | 1992-12-31 | 1992-12-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA939804B true ZA939804B (en) | 1994-08-18 |
Family
ID=25545857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA939804A ZA939804B (en) | 1992-12-31 | 1993-12-30 | Immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0604727A1 (xx) |
AU (1) | AU5279993A (xx) |
CA (1) | CA2112508A1 (xx) |
NZ (1) | NZ250555A (xx) |
ZA (1) | ZA939804B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6238676B1 (en) | 1992-12-10 | 2001-05-29 | Brigham And Women's Hospital | Presentation of hydrophobic antigens to T-cells by CD1 molecules |
US7063844B2 (en) | 1992-12-10 | 2006-06-20 | The Brigham And Women's Hospital, Inc. | Presentation of hydrophobic antigens to T-cells by CD1 molecules |
EP0609739A1 (en) * | 1993-02-02 | 1994-08-10 | American Cyanamid Company | Method of reversing immunosuppression in vaccines |
NZ289721A (en) * | 1994-07-07 | 1997-11-24 | Immunex Corp | Fusion proteins comprising gm-csf and antigens; their expression on yeast |
EP0784486B1 (en) * | 1994-10-05 | 2006-04-05 | Vanderbilt University | Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
EP2949339A1 (en) | 2014-05-29 | 2015-12-02 | Ospedale San Raffaele S.r.l. | Agonist of CD1c-restricted T cells and uses thereof |
CN114404583A (zh) * | 2022-01-25 | 2022-04-29 | 龙岩学院 | 一种副猪嗜杆菌佐剂疫苗的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) * | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
SE8405493D0 (sv) * | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
GB8919819D0 (en) * | 1989-09-01 | 1989-10-18 | Coopers Animal Health | Complexes having adjuvant activity |
-
1993
- 1993-10-25 EP EP93117244A patent/EP0604727A1/en not_active Withdrawn
- 1993-12-22 NZ NZ250555A patent/NZ250555A/en unknown
- 1993-12-29 CA CA002112508A patent/CA2112508A1/en not_active Abandoned
- 1993-12-30 ZA ZA939804A patent/ZA939804B/xx unknown
- 1993-12-30 AU AU52799/93A patent/AU5279993A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ250555A (en) | 1995-04-27 |
EP0604727A1 (en) | 1994-07-06 |
CA2112508A1 (en) | 1994-07-01 |
AU5279993A (en) | 1994-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA934890B (en) | Use of Gm-CSF as a vaccine adjuvant | |
GB8822749D0 (en) | Vaccine containing tumour antigens & adjuvants | |
IL103928A0 (en) | Expression of specific immunogens using viral antigens | |
HK1010097A1 (en) | Vaccine composition containing adjuvants | |
GB8907914D0 (en) | Vaccine preparation | |
AU709406C (en) | Combined vaccines comprising hepatitis B surface antigen and other antigens | |
GR3022174T3 (en) | Hepatitis vaccines containing 3-o-deacylated monophoshoryl lipid a. | |
IL101290A0 (en) | Vaccine formulations | |
NZ232190A (en) | Intraperitoneal vaccine for producing an iga response | |
AU5941486A (en) | Tetanus vaccine from cloned antigen | |
PL307402A1 (en) | Vaccine containing a hepatitis a virus | |
HU9300010D0 (en) | Glycoprotein vaccine named ehv-4 | |
ZA939804B (en) | Immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen | |
EP0290565A4 (en) | VACCINE CONTAINING TICK ANTIGENS. | |
ZW19090A1 (en) | Malaria vaccine | |
GB2248186B (en) | Preparation of vaccines | |
ZW7290A1 (en) | Malaria vaccine | |
AU3751093A (en) | Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine | |
AU2971692A (en) | Flystrike antigen and vaccine and method for preparation | |
GB8828523D0 (en) | St-lt recombinant antigen vaccines | |
GB8712042D0 (en) | Virus & vaccine | |
AU3931197A (en) | Vaccines and antigenic conjugates | |
GB9207360D0 (en) | Antigen preparation | |
ZA909516B (en) | Novel vaccine | |
IL95006A0 (en) | Oral vaccines |